specification indicates Engvall never conveyed any concern with the magnitude of the affinity of the monoclonals and antigens used. On the other hand, Engvall did have concern for the specificity of the monoclonals. Indeed, the reason stated in the specification for employing monoclonals in her assays was the high specificity of the these antibodies. Engvall Application 06/539,754, specification, p. 4, lines 13 to 25. Engvall's specification begins by identifying that the technological field of the invention is sandwich assays involving the use of two antibodies which are active against the same antigen: [T]he present invention relates to a method for the determination of an antigen (I) in solution, in which determination said antigen (I) is reacted with an antibody (II), which is directed against the antigen (I) and with an antibody (III), which is directed against the antigen (I) and is labeled with an analytically indicatable atom or group and is soluble in the liquid in the presence of which the determination is carried out, to the formation of a conjugate comprising said antigen (I) and said antibodies (II) and (III), which conjugate is insoluble or is made insoluble, whereafter the analytically indicatable atom or group is determined in the insoluble or insolubilized conjugate and/or in the solution. Engvall Application 06/539,754, specification, p. 1, lines 3-14. The specification goes on to indicate that assay methods using biospecific affinity reactions are well known. At page 2, lines 1-11, of her specification Engvall states: A great number of assay methods involving biospecific affinity reactions [are] known in which methods a first immunochemical reactant is reacted with a second immunochemical reactant exhibiting biospecific affin[ity] to said first reactant and then a third immunochemical reactant, which exhibits biospecific affinity to the first or the . . . second reactant (i.e., is an immunochemical counterpart to the first or the second reactant) is reacted with its counterpart to the formation of a conjugate comprising said first, second and third reactants, one of said reactants being labeled with an analytically indicatable atom or group of atoms. Engvall further notes that in order to determine the presence of the second reactant, the labeled conjugate must be separated from the labeled but unreacted component. She indicates that this is commonly done by using, as one of the reactants, a component bound to an insoluble polymer. The labeled conjugate is removed by simply removing the polymer with the bound conjugate from 19Page: Previous 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 NextLast modified: November 3, 2007